1 | 4cc of lidocaïne® | - | - | - | - | 1件: 149 149 |
2 | 9060X | - | - | - | - | 2件: 13 13, 149 |
3 | Anatomical Landmark-guided Suprascapular Nerve Block | - | - | - | - | 1件: 149 149 |
4 | Baclofen | 1件: Baclofen Baclofen | 1件: D00241
D00241
| 2件: GABBR1 GABBR1, GABBR2 💬 | 7件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 8件: 2 2, 10, 13, 18, 65, 70, 149, 206 |
5 | Balance | 1件: Isoxaflutole Isoxaflutole | - | - | - | 5件: 6 6, 11, 46, 81, 149 |
6 | Botox | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 7件: 2 2, 6, 13, 47, 51, 149, 226 |
7 | Botulinum Toxin | - | - | - | - | 3件: 6 6, 13, 149 |
8 | Botulinum toxin A | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 4件: 13 13, 51, 149, 226 |
9 | BOTULINUM TOXIN TYPE A | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 10件: 2 2, 5, 6, 7, 13, 15, 17, 70, 113, 149 |
10 | Brivaracetam | 1件: Brivaracetam Brivaracetam | 1件: D08879
D08879
| 1件: SV2A SV2A 💬 | 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 2件: 149 149, 309 |
11 | Edonerpic | 1件: Edonerpic Edonerpic | - | - | - | 1件: 149 149 |
12 | FENFLURAMINE | 1件: Fenfluramine Fenfluramine | 1件: D07945
D07945
| 5件: HTR1D HTR1D, HTR2A, HTR2C, SIGMAR1, SLC6A4 💬 | 10件: Amyotrophic lateral sclerosis Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬 | 4件: 140 140, 144, 145, 149 |
13 | Gradient | - | - | - | - | 1件: 149 149 |
14 | HC-58 | - | - | - | - | 1件: 149 149 |
15 | Lacosamide | 1件: Lacosamide Lacosamide | 1件: D07299
D07299
| 2件: SCN3A SCN3A, SCN9A 💬 | 1件: Taste transduction Taste transduction 💬 | 4件: 2 2, 46, 149, 298 |
16 | Medicinal air | - | - | - | - | 1件: 149 149 |
17 | MEOPA | 1件: Nitrous oxide Nitrous oxide | 1件: D00102
D00102
| - | - | 1件: 149 149 |
18 | OnabotulinumtoxinA | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 4件: 6 6, 13, 149, 226 |
19 | Onabotulinumtoxina for Injection | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 149 149 |
20 | Oxybate | 1件: gamma-Hydroxybutyric acid gamma-Hydroxybutyric acid | - | - | - | 2件: 6 6, 149 |
21 | Padsevonil | 1件: Padsevonil Padsevonil | 1件: D11842
D11842
| 3件: SV2A SV2A, SV2B, SV2C 💬 | 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 1件: 149 149 |
22 | Placebo | - | - | - | - | 28件: 3 3, 5, 6, 11, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 |
23 | Sodium Oxybate | 2件: Sodium oxybate Sodium oxybate, gamma-Hydroxybutyric acid | 1件: D05866
D05866
| - | - | 2件: 6 6, 149 |
24 | SPM927 | - | - | - | - | 1件: 149 149 |
25 | T-817MA | - | - | - | - | 1件: 149 149 |
26 | Time delay treatment of botulinum toxin | - | - | - | - | 1件: 149 149 |
27 | Triheptanoin | 1件: Triheptanoin Triheptanoin | 1件: D11465
D11465
| - | - | 10件: 2 2, 8, 65, 149, 156, 248, 256, 257, 317, 324 |
28 | Ucb 34714 | - | - | - | - | 2件: 149 149, 309 |
29 | Ultrasound-guided Suprascapular Nerve Block | - | - | - | - | 1件: 149 149 |
30 | Whole Exome Sequencing | - | - | - | - | 3件: 65 65, 120, 149 |